Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Variceal bleeding. Can it be prevented?

J Korula1

  • 1Department of Medicine, University of Southern California School of Medicine, Los Angeles, USA.

Postgraduate Medicine
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.

Alimentary pharmacology & therapeutics·2006
Same author

Generalized myokymia as a unique association with gluten-sensitive enteropathy.

European neurology·2000
Same author

Patients with ascites have higher variceal pressure and wall tension than patients without ascites.

The American journal of gastroenterology·2000
Same author

Peritoneal mucinous carcinomatosis. A possible explanation for an unusual laparoscopic appearance.

Digestive diseases and sciences·1997
Same author

Low albumin gradient ascites complicating severe pseudomembranous colitis.

Gastroenterology·1997
Same author

Analysis of long-term endoscopic surveillance during follow-up after variceal sclerotherapy from a 13-year experience.

The American journal of medicine·1997

Portal hypertension and chronic liver disease can cause esophageal and gastric varices. Beta-blockers are beneficial for preventing initial bleeding from these varices.

Area of Science:

  • Gastroenterology
  • Hepatology
  • Internal Medicine

Background:

  • Esophageal and gastric varices are complications of portal hypertension and advanced chronic liver disease.
  • Variceal bleeding leads to significant mortality and morbidity.
  • The precise mechanisms of varix rupture remain unclear, but elevated pressures and variceal wall tension are implicated.

Purpose of the Study:

  • To review the factors contributing to variceal bleeding.
  • To discuss the efficacy of various treatments for preventing initial variceal bleeding.
  • To highlight the role of nonselective beta-adrenergic blocking drugs in primary prophylaxis.

Main Methods:

  • Literature review of studies on esophageal and gastric varices.
  • Analysis of factors influencing varix rupture, including pressure dynamics and varix size.

Related Experiment Videos

  • Evaluation of treatment strategies for variceal bleeding prevention.

    • Main Results:

    • Large varices and the presence of red wales are associated with increased bleeding risk.
    • Surgical interventions and endoscopic sclerotherapy are not effective for preventing initial bleeding.
    • Nonselective beta-adrenergic blocking drugs demonstrate efficacy in primary prophylaxis of variceal bleeding.

    Conclusions:

    • Nonselective beta-adrenergic blocking drugs are recommended for the primary prevention of variceal bleeding.
    • Careful patient selection and monitoring are crucial for successful treatment outcomes.
    • Further research into the exact mechanisms of varix rupture may lead to improved therapeutic strategies.